echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > "4 + 7" purchasing with volume, expanding the scope of medical representatives to change jobs?

    "4 + 7" purchasing with volume, expanding the scope of medical representatives to change jobs?

    • Last Update: 2019-09-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [industry trends of pharmaceutical network] recently, the results of 4 + 7 expansion plan were officially published Some analysts pointed out that for most 4 + 7 varieties, it is almost impossible for enterprises to make money In the future, enterprises will face the road of transformation and upgrading The varieties that really make money are innovative drugs, improved new drugs, race to imitate and difficult to imitate This result has a great impact on the pharmaceutical representatives of enterprises As we all know, the price of selected drugs is so low that there is no room for clinical operation However, for 70% of the market share of the country, major pharmaceutical companies will fight hard All in all, drugs involving 25 generic names, whether selected or not, will be traded at reduced prices In fact, the purpose of national implementation of generic drug consistency evaluation is to replace the original research drug Generic drugs that pass the consistency evaluation of quality and efficacy (and the original research drug) are just the important "chips" for the implementation of strategic purchase of China's medical insurance In this case, there is no room for a lot of related drugs, and there is no need to hire as many medical representatives as usual What many representatives can do is to change products or be eliminated In addition, the opportunity to promote job hopping and elimination of medical workers is also the adjustment of the new medical insurance catalog 20 national key monitoring drugs are transferred out of the catalog, or it will also lead to the job mobility of a group of medical representatives A medical representative of a leading pharmaceutical company told the author: "the company has reorganized a team for the original irbesartan and clopidogrel bisulfate, which is mainly engaged in the company's products purchased with volume." According to his introduction, colleagues who used to be irbesartan or clopidogrel bisulfate basically went to the new team, and the original team was dissolved The two products have been handed over to the medical representatives who specialize in purchasing products with volume In addition, according to another regional manager of a foreign pharmaceutical company, a large number of managers left the original team as the drugs they were responsible for went into the volume purchasing It can be seen that after 4 + 7 volume procurement, the post turbulence of pharmaceutical representatives in private and foreign enterprises is not small However, after purchasing with quantity, can medical representatives only transfer or change jobs? Not necessarily! After the 4 + 7 national expansion, some medical representatives indeed entered a turbulent period, but there must be a communication channel before building the relationship between drugs and doctors Such medical representatives who can build the relationship are competitive and indispensable at all times If the products are selected in the volume purchase, only one product needs to be changed, and those who are eliminated may be colleagues who only meet customers and sell with money Some enterprise personage told the author that "our company 's products were purchased with quantity last year, and today' s 4+7 national expansion won the bid again However, none of my representatives left voluntarily After another product of our company is added to the volume purchase, it has no impact on us, because we have other products to support the income of future pharmaceutical representatives " In this way, although the 4 + 7 national expansion, the enterprises still need medical representatives However, with the deepening of health care reform, the period of post turbulence in the industry will continue for some time In addition, the degree of specialization of medical representatives in the future will only be higher and higher Therefore, only by relying on the efforts of the medical representatives to improve their professional skills, so as to adapt to the changing situation, can we face the future without fear After all, people with real ability can eat everywhere!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.